CommercialPrior AuthHigh impact
05.00.77f, Implantable Cardioverter Defibrillators
Independence Blue Cross·Cardiology, Cardiothoracic Surgery, Critical Care·Medical Policy
Effective date
Nov 3, 2025
We identified it
Jun 19, 2026
Summary
Policy 05.00.77f has been revised effective November 3, 2025, updating medical necessity criteria for Implantable Cardioverter Defibrillators (ICDs). This is a recent policy change that may affect prior authorization requirements, coverage determinations, or documentation standards for ICD implantation procedures. The billing team must review the full policy details to identify specific criteria changes that impact claim submission and approval processes.
Action Required
By November 3, 2025: Billing team must obtain and review the complete policy text at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=11&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#commercial-05-00-77f to identify specific medical necessity criteria changes. Providers and billing staff must update prior authorization submission templates and documentation checklists to reflect new requirements. Update billing system rules to enforce revised criteria. Ensure all ICD-related claims submitted on or after November 3, 2025 comply with new medical necessity standards. Claims submitted without meeting updated criteria will be denied.